8 July 2025NewsFuture of IPHa Kung Wong, Venable | Karen Martin, Ipsen | Nitin Virmalwar, Stoke Therapeutics | Jennifer Moitoso, Biogen

WATCH: Mastering the art of IP transactions—due diligence, valuation, and deal-making

LSPN brings together experts from Venable, Ipsen, Stoke Therapeutics, and Biogen to analyse best practices for IP transactions, from due diligence and valuation to structuring deals.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Atif Choudhury at achoudhury@worldipreview.com

Legal AI tools face off in a watershed patent battle

Five generations at work: How teams are bridging the gap

12-year-old inventor finds her voice through AI

Report: 85% of in-house counsel want IP service providers to embrace AI

In-house interview: Why tackling piracy is ‘like the war on drugs’

Start to finish: Marathon milestone highlights IP’s role in sport

A quantum leap? UK’s ‘commercialisation skills centre’ plays key role in tech ambition

WATCH: Getting a seat at the top table — advocate for your IP team and their value

WATCH: Mastering the art of IP transactions—due diligence, valuation, and deal-making

Editor's picks

Editor's picks

More articles